Plus, news on Antabio’s €25 million Series B, Athira’s Alzheimer’s data, Connect’s asthma results and Liquidia’s $25 million raise.
Almirall, etherna’s new partnership: The companies plan to develop new mRNA therapies for severe skin diseases, including some skin cancers. Almirall is paying etherna an undisclosed upfront payment, plus up to €300 million ($324 million) in potential milestones. — Jaimy Lee
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.